Literature DB >> 26297884

Incorporation of fibrin into a collagen-glycosaminoglycan matrix results in a scaffold with improved mechanical properties and enhanced capacity to resist cell-mediated contraction.

Claire M Brougham1, Tanya J Levingstone2, Stefan Jockenhoevel3, Thomas C Flanagan4, Fergal J O'Brien5.   

Abstract

Fibrin has many uses as a tissue engineering scaffold, however many in vivo studies have shown a reduction in function resulting from the susceptibility of fibrin to cell-mediated contraction. The overall aim of the present study was to develop and characterise a reinforced natural scaffold using fibrin, collagen and glycosaminoglycan (FCG), and to examine the cell-mediated contraction of this scaffold in comparison to fibrin gels. Through the use of an injection loading technique, a homogenous FCG scaffold was developed. Mechanical testing showed a sixfold increase in compressive modulus and a thirtyfold increase in tensile modulus of fibrin when reinforced with a collagen-glycosaminoglycan backbone structure. Human vascular smooth muscle cells (vSMCs) were successfully incorporated into the FCG scaffold and demonstrated excellent viability over 7 days, while proliferation of these cells also increased significantly. VSMCs were seeded into both FCG and fibrin-only gels at the same seeding density for 7 days and while FCG scaffolds did not demonstrate a reduction in size, fibrin-only gels contracted to 10% of their original diameter. The FCG scaffold, which is composed of natural biomaterials, shows potential for use in applications where dimensional stability is crucial to the functionality of the tissue. STATEMENT OF SIGNIFICANCE: Fibrin is a versatile scaffold for tissue engineering applications, but its weak mechanical properties leave it susceptible to cell-mediated contraction, meaning the dimensions of the fibrin construct will change over time. We have reinforced fibrin with a collagen glycosaminoglycan matrix and characterised the mechanical properties and bioactivity of the reinforced fibrin (FCG). This is the first scaffold manufactured from all naturally derived materials that resists cell-mediated contraction. In fact, over 7 days, the FCG scaffold fully resisted cell-mediated contraction of vascular smooth muscle cells. This FCG scaffold has many potential applications where natural scaffold materials can encourage regeneration.
Copyright © 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular scaffold; Fibrin; Heart valve; Tissue engineering

Mesh:

Substances:

Year:  2015        PMID: 26297884     DOI: 10.1016/j.actbio.2015.08.022

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  14 in total

Review 1.  Injectable Hydrogels for Cardiac Tissue Engineering.

Authors:  Brisa Peña; Melissa Laughter; Susan Jett; Teisha J Rowland; Matthew R G Taylor; Luisa Mestroni; Daewon Park
Journal:  Macromol Biosci       Date:  2018-05-07       Impact factor: 4.979

Review 2.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

3.  Composition of elastin like polypeptide-collagen composite scaffold influences in vitro osteogenic activity of human adipose derived stem cells.

Authors:  Bhuvaneswari Gurumurthy; Patrick C Bierdeman; Amol V Janorkar
Journal:  Dent Mater       Date:  2016-08-11       Impact factor: 5.304

4.  An efficient, non-viral dendritic vector for gene delivery in tissue engineering.

Authors:  D P Walsh; A Heise; F J O'Brien; S-A Cryan
Journal:  Gene Ther       Date:  2017-09-14       Impact factor: 5.250

Review 5.  An overview of bio-actuation in collagen hydrogels: a mechanobiological phenomenon.

Authors:  Pearlin Hameed; Geetha Manivasagam
Journal:  Biophys Rev       Date:  2021-05-20

6.  Three Dimensional Collagen Scaffold Promotes Intrinsic Vascularisation for Tissue Engineering Applications.

Authors:  Elsa C Chan; Shyh-Ming Kuo; Anne M Kong; Wayne A Morrison; Gregory J Dusting; Geraldine M Mitchell; Shiang Y Lim; Guei-Sheung Liu
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

7.  Differentiation of human adipose-derived stem cells into cardiomyocyte-like cells in fibrin scaffold by a histone deacetylase inhibitor.

Authors:  Zahra Bagheri-Hosseinabadi; Parvin Salehinejad; Seyed Alireza Mesbah-Namin
Journal:  Biomed Eng Online       Date:  2017-11-23       Impact factor: 2.819

Review 8.  Advances in the Biofabrication of 3D Skin in vitro: Healthy and Pathological Models.

Authors:  Matthew J Randall; Astrid Jüngel; Markus Rimann; Karin Wuertz-Kozak
Journal:  Front Bioeng Biotechnol       Date:  2018-10-31

9.  Functionalising Collagen-Based Scaffolds With Platelet-Rich Plasma for Enhanced Skin Wound Healing Potential.

Authors:  Ronaldo J F C do Amaral; Noora M A Zayed; Elena I Pascu; Brenton Cavanagh; Chris Hobbs; Francesco Santarella; Christopher R Simpson; Ciara M Murphy; Rukmani Sridharan; Arlyng González-Vázquez; Barry O'Sullivan; Fergal J O'Brien; Cathal J Kearney
Journal:  Front Bioeng Biotechnol       Date:  2019-12-03

10.  Hydrogel scaffolds based on blood plasma cryoprecipitate and collagen derived from various sources: Structural, mechanical and biological characteristics.

Authors:  Marfa N Egorikhina; Diana Ya Aleynik; Yulia P Rubtsova; Grigory Ya Levin; Irina N Charykova; Ludmila L Semenycheva; Marina L Bugrova; Evgeniy A Zakharychev
Journal:  Bioact Mater       Date:  2019-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.